NCT01697865

Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction

Completed NA Last updated 25 January 2021

What this trial tests

NA trial testing Transfer group in Osteoarthritis of the Shoulder in 33 participants. Completed in 21 September 2020.

Timeline

21 June 2012

Primary endpoint
12 February 2019

21 September 2020

Quick facts

Lead sponsor	OrthoCarolina Research Institute, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	33
Start date	21 June 2012
Primary completion	12 February 2019
Estimated completion	21 September 2020
Sites	1 location across United States

Drugs / interventions tested

• Transfer group
• Control group — full drug profile →

Conditions studied

• Osteoarthritis of the Shoulder — all drugs for Osteoarthritis of the Shoulder →

Sponsor

OrthoCarolina Research Institute, Inc.

Who can join

18 and older, any sex, with Osteoarthritis of the Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this study is to compare the clinical benefit and safety of two different surgical techniques of primary reverse total shoulder arthroplasty for the treatment of shoulder pseudoparalysis from chronic rotator cuff disease with associated teres minor dysfunction. The first surgical technique includes a concomitant latissimus and teres major transfer (transfer group) and the second technique does not include a concomitant latissimus and teres major transfer (control group).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy.
   Craig RS, Goodier H, Singh JA, Hopewell S, et al · · 2020 · cited 34× · PMID 32315453 · DOI 10.1002/14651858.cd012879.pub2